PUBLIC EXPOSE
PT DARYA-VARIA LABORATORIA TBKHotel Fairmont, 7 Mei 2018
Jakarta1
Topik / Topics :1. Tinjauan Pasar
Market Overview
2. Sekilas tentang DVLDVL at a Glance
3. Tinjauan Bisnis DVL Tahun 2017DVL Business Overview FY 2017
4. Kinerja DVL Kuartal 1-2018 DVL Performance 1st Q-2018 2
TINJAUAN
PASARM A R K E T O V E R V I E W
3
Sebagaimana dilaporkan oleh Badan Pusat Statistik (BPS), 2017: Pendapatan Domestik Bruto (PDB) Rp13.588,8 triliun PDB per kapita sebesar Rp51,89 juta atau USD 3.876,8 Komponen konsumsi rumah tangga berkontribusi 56,13% Belanja pemerintah berkontribusi 9,10%
As reported by Central Statistics Agency (BPS), 2017: Gross Domestic Product (GDP) Rp13,588.8 trillion GDP per capita Rp51.89 million or USD 3,876.8. Household consumption contributed 56.13% Government consumption 9.10%
Perekonomian Indonesia tumbuh 5,07%
Indonesia’s economy grew by 5.07%
4.3 4.3
3.53.6
3.4
3.2
5.0
4.8
5.0 5.1
2.5
3
3.5
4
4.5
5
5.5
6
6.5
7
2014 2015 2016 2017
Emerging market World Indonesia
5,07
Kondisi UmumGeneral Conditions
4
Kondisi UmumGeneral Conditions
Stabilitas makroekonomi terjaga dengan baik:- inflasi 3,61%- nilai tukar Rp13.548 per dolar AS
Macroeconomic stability was well-maintained:- inflation at 3.61%- exchange rate closed 2017 at Rp13.548 to the US dollar
5
Semakin dekatnya penerapan untuk kriteria halalImpending implementation of halal compliance
Peningkatan cakupan Program Jaminan Kesehatan Nasional (JKN) yang diselenggarakan BPJS Kesehatan hingga 70% penduduk IndonesiaNational Health Insurance (NHI) program by BPJS Kesehatan, increased its coverage to about 70% of Indonesian citizens
Pengetatan peraturan oleh Badan Pengawas Obat dan Makanan(BPOM) NasionalTightened regulations by the National Agency of Food & Drug Control (BPOM)
Perkembangan yang mempengaruhi industri farmasi:Developments that impacted the pharmaceutical industry:
Kondisi UmumGeneral Conditions
6
SEKILAS
TENTANG DVL
D V L AT A G L A N C E
7
8
9
Segmen Bisnis UtamaMain Business Segments
Bisnis Obat ResepPrescription Business
Bisnis Consumer HealthConsumer Health Business
Bisnis Ekspor& Jasa Toll Manufacturing
Export & Toll Manufacturing Business
10
Fasilitas ProduksiProduction Facilities
Citeureup, BogorProduk Steril & Padat
Sterile & Solid
Gunung Putri, BogorKapsul Lunak, Cairan, KosmetikSoft Capsule, Liquid, Cosmetic
11
IKHTISAR
DVLD V L H I G H L I G H T S
12
Peluncuran Produk BaruNew Products Launch
MARCH 2017DIPITENZ
APRIL 2017IAL SYSTEM
OCTOBER 2017PROTEZID
NOVEMBER 2017ESOZID 13
Kegiatan PemasaranMarketing Activities
Scientific Seminars
Medical Science Centre
PR & On-Ground Activation
Digital Marketing
14
TINJAUAN BISNIS
DVL TAHUN 2017
D V L B U S I N E S S O V E R V I E W
F Y 2 0 1 7
15
Kinerja DVL Tahun 2017DVL Performance FY 2017
Penjualan Bersih (Net Sales)(Miliar/Billion Rupiah)
Pertumbuhan(Growth)
Bisnis Obat Resep(Prescription Business)
537 12%
Bisnis Kesehatan Konsumen(Consumer Health Business)
746 14%
Bisnis Ekspor & Jasa Toll Manufacturing(Export & Toll Manufacturing Business)
292 (8%)
Jumlah Penjualan Bersih / Total Net Sales 1.575 8,6%
16
LAPORAN LABA RUGI STATEMENT OF PROFIT OR LOSS
Uraian(dalam miliar Rupiah)
2017 2016% Pertumbuhan
% GrowthDescription
(in billion Rupiah)
Laba Bruto 894 801 12% Gross Income
Laba Usaha 220 204 8% Operating Income
Laba Bersih 162 152 7% Net Income
Marjin Laba Bersih 10% 10% - Net Income Margin
Laba bersih per saham(Rupiah penuh)
145 136 7%Net Income per Share (full rupiah)
17
Uraian(dalam miliar Rupiah)
2017 2016Increase/
(Decrease)Description
(in billion Rupiah)
Total Aset 1.641 1.531 7% Total Assets
Aset Lancar 1.176 1.069 10% Current Assets
Total Liabilitas 525 452 16% Total Liabilities
Ekuitas 1.116 1.080 3% Equity
LAPORAN POSISI KEUANGAN STATEMENT OF FINANCIAL POSITION
18
LAPORAN ARUS KASSTATEMENT OF CASH FLOWS
Uraian(dalam miliar Rupiah)
2017 2016Increase/ Decrease
Description (in billion Rupiah)
Arus kas dari operasional
231 187 23%Cash flows from operations
Arus kas untuk aktivitas investasi
(41) (197) (79%)Cash flows used in investing activities
Arus kas untuk aktivitas pendanaan
(112) (39) 187%Cash flows used in financing activities
19
D V L P E R F O R M A N C E
1 s t Q - 2 0 1 8
KINERJA DVL
KUARTAL 1-2018
20
Kinerja Kuartal 1-2018Q1 2018 Performance
I. Total Penjualan Bersih DVL sebesar Rp 430 miliar- DVL tumbuh sebesar 8%
II. Apa yang mendukung kinerja bisnis?- Pertumbuhan Bisnis Obat Resep +20%- Pertumbuhan Ekspor dan Jasa Toll
Manufacturing +22%
III. Tantangan bisnis
- Menurunnya industri farmasi
- Consumer Health -7%
I. Total DVL Net Sales at Rp 430 bio- DVL grew by 8%
II. What drove the business?
- Prescription Business +20% growth
- Export and Toll Manufacturing +22% growth
III. Business challenges
- Pharma industry in declined
- Consumer Health -7%
IV. Keuangan :
- Laba Bruto, Laba Usaha & Laba Bersih DVL
tetap terjaga
IV. Financials :
- DVL Gross Income, Operating Income &
Net Profit are on track
V. Program Sampai Dengan Akhir Tahun yang
terencanaV. Balance Year Program in place
21
SESI
TANYA JAWABQ U E S T I O N S A N D A N S W E R S
D V L P U B L I C E X P O S E
22
23